Table 2 Impact of in-hospital epinephrine on 7-day survival and secondary outcomes
| Â | Epinephrine | no-Epinephrine | P value | OR | 95% CI |
|---|---|---|---|---|---|
Unadjusted analyses | |||||
 Survival at 7 days, n (%; 95%CI) | 9 (1.1%; 0.4–1.8%) | 11 (5.3%; 2.2–8.3%) | < 0.01 | 0.20 | 0.08–0.48 |
 ROSC, n (%; 95%CI) | 144 (17.5%; 14.9–20.1%) | 24 (11.6%; 7.2–15.9%) | 0.04 | 1.62 | 1.02–2.57 |
Propensity score matching | |||||
 Survival at 7 days, n (%; 95%CI) | 1 (0.6%; 0.0–1.7%) | 9 (5.1%; 1.8–8.3%) | 0.02 | 0.11 | 0.01–0.85 |
 ROSC, n (%; 95%CI) | 32 (18.0%; 12.3–23.6%) | 16 (9.0%; 4.8–13.2%) | 0.01 | 2.21 | 1.16–4.19 |